N
Power Law company profile
NeoGenomics Laboratories
Biotech & Life Sciences · Fort Myers, United States · Founded 2002 · IPO 2013 Unicorn
Valuation
$1.43B
Market cap · Apr/2026
Revenue
$727M
Latest reported FY
Global footprint
Where NeoGenomics Laboratories has talent and traffic
AI talent share
0.3%
of workforce is AI talent
(6 of 1,757 staff)
(6 of 1,757 staff)
Core AI30.17%
Other AI30.17%
Non-AI workforce1,75199.66%
Web traffic by country
57K
monthly visits
across markets
across markets
🇺🇸 United States84%
🇮🇳 India5.6%
🇬🇧 United Kingdom5.4%
🇨🇦 Canada2.6%
🇵🇭 Philippines1.2%
Patent intelligence
$12M patent portfolio · 11 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$12M
0.85% of market cap · 26.3× smaller than top peer Exact Sciences ($319M)
11 active patent families
Where NeoGenomics Laboratories innovates
OncologyBioinformaticsWild typeLocked nucleic acidPathology
Above peer median on Legal, Strategic, Market
Quality vs same-sector peers
NeoGenomics Laboratories on the five Patsnap quality dimensions
NeoGenomics Laboratories in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where NeoGenomics Laboratories concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across NeoGenomics Laboratories and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee NeoGenomics Laboratories on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.